• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

变异对新发帕金森病患者长期临床进展和死亡率的影响。

Impact of variants on long-term clinical progression and mortality in incident Parkinson's disease.

机构信息

John van Geest Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, Cambridgeshire, UK

Wellcome Trust Medical Research Council - Cambridge Stem Cell Institute, Cambridge, UK.

出版信息

J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):695-702. doi: 10.1136/jnnp-2020-322857. Epub 2020 Apr 17.

DOI:10.1136/jnnp-2020-322857
PMID:32303560
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7361014/
Abstract

INTRODUCTION

Variants in the gene have been identified as a common risk factor for Parkinson's disease (PD). In addition to pathogenic mutations (those associated with Gaucher disease), a number of 'non-pathogenic' variants also occur at increased frequency in PD. Previous studies have reported that pathogenic variants adversely affect the clinical course of PD. The role of 'non-pathogenic' variants on PD course is less clear. In this study, we report the effect of variants in incident PD patients with long-term follow-up.

METHODS

The study population consisted of patients in the Cambridgeshire Incidence of Parkinson's disease from General Practice to Neurologist and Parkinsonism: Incidence, Cognition and Non-motor heterogeneity in Cambridgeshire cohorts. Patients were grouped into non-carriers, carriers of 'non-pathogenic' variants and carriers of pathogenic mutations. Survival analyses for time to development of dementia, postural instability and death were carried out. Cox regression analysis controlling for potential confounders were used to determine the impact of variants on these outcome measures.

RESULTS

variants were identified in 14.4% of patients. Pathogenic and 'non-pathogenic' variants were associated with the accelerated development of dementia and a more aggressive motor course. Pathogenic variants were associated with earlier mortality in comparison with non-carriers, independent of the development of dementia.

DISCUSSION

variants, including those not associated with Gaucher disease, are common in PD and result in a more aggressive disease course.

摘要

简介

基因中的变异已被确定为帕金森病(PD)的常见风险因素。除了致病性突变(与戈谢病相关的突变)外,许多“非致病性”变异在 PD 中也以较高的频率发生。先前的研究报告称,致病性变异会对 PD 的临床病程产生不利影响。“非致病性”变异对 PD 病程的作用尚不清楚。在这项研究中,我们报告了具有长期随访的新发 PD 患者中 变异的作用。

方法

研究人群包括来自剑桥郡普通实践到神经病学家和帕金森病:发病率、认知和剑桥郡队列中非运动障碍异质性的帕金森病的剑桥郡发病中的患者。患者分为非携带者、“非致病性”变异携带者和致病性 变异携带者。对痴呆、姿势不稳和死亡的发展时间进行生存分析。使用 Cox 回归分析控制潜在混杂因素,以确定 变异对这些结局的影响。

结果

在 14.4%的患者中发现了 变异。致病性和“非致病性”变异与痴呆的加速发展和更具侵袭性的运动过程有关。与非携带者相比,致病性 变异与死亡率的提前有关,而与痴呆的发展无关。

讨论

包括与戈谢病无关的 变异在内的 变异在 PD 中很常见,导致更具侵袭性的疾病过程。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26a/7361014/11caec6225fa/jnnp-2020-322857f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26a/7361014/5121eee8c0a8/jnnp-2020-322857f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26a/7361014/077c8bb92e37/jnnp-2020-322857f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26a/7361014/11caec6225fa/jnnp-2020-322857f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26a/7361014/5121eee8c0a8/jnnp-2020-322857f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26a/7361014/077c8bb92e37/jnnp-2020-322857f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a26a/7361014/11caec6225fa/jnnp-2020-322857f03.jpg

相似文献

1
Impact of variants on long-term clinical progression and mortality in incident Parkinson's disease.变异对新发帕金森病患者长期临床进展和死亡率的影响。
J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):695-702. doi: 10.1136/jnnp-2020-322857. Epub 2020 Apr 17.
2
Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation.帕金森病的影像学与遗传学:GBA1 突变评估。
J Neurol. 2022 Oct;269(10):5347-5355. doi: 10.1007/s00415-022-11181-0. Epub 2022 May 23.
3
Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.GBA突变型帕金森病中的葡萄糖脑苷脂酶活性
J Clin Neurosci. 2016 Jun;28:185-6. doi: 10.1016/j.jocn.2015.12.004. Epub 2016 Feb 5.
4
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
5
Early-onset Parkinson's disease in a patient with a rare homozygous pathogenic GBA1 variant and no Gaucher disease symptoms.一名患有罕见纯合致病性GBA1变异且无戈谢病症状的早发性帕金森病患者。
Neurogenetics. 2025 Feb 15;26(1):28. doi: 10.1007/s10048-025-00810-1.
6
The effect of polygenic risk score on PD risk and phenotype in G2019S and carriers.多基因风险评分对G2019S及携带者帕金森病风险和表型的影响。
J Parkinsons Dis. 2025 Mar;15(2):291-299. doi: 10.1177/1877718X241310722. Epub 2025 Jan 17.
7
Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.帕金森病 GBA1 变异分类:GBA1-PD 浏览器。
Mov Disord. 2023 Mar;38(3):489-495. doi: 10.1002/mds.29314. Epub 2023 Jan 4.
8
Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.GBA 相关散发性帕金森病患者的胆碱能神经支配分布。
Brain. 2024 Mar 1;147(3):900-910. doi: 10.1093/brain/awad323.
9
Evolution of prodromal parkinsonian features in a cohort of mutation-positive individuals: a 6-year longitudinal study.队列研究中突变阳性个体前驱帕金森特征的演变:一项 6 年纵向研究。
J Neurol Neurosurg Psychiatry. 2019 Oct;90(10):1091-1097. doi: 10.1136/jnnp-2019-320394. Epub 2019 Jun 20.
10
A Global Perspective of -Related Parkinson's Disease: A Narrative Review.与[具体内容缺失]相关的帕金森病的全球视角:一篇叙述性综述
Genes (Basel). 2024 Dec 16;15(12):1605. doi: 10.3390/genes15121605.

引用本文的文献

1
Risk factors and predictors for Lewy body dementia: a systematic review.路易体痴呆的风险因素和预测因素:一项系统综述。
NPJ Dement. 2025;1(1):20. doi: 10.1038/s44400-025-00022-2. Epub 2025 Aug 4.
2
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa-Carbidopa Intestinal Gel: A Nation-Wide, Multicenter, Longitudinal, "Real-World" Study. The EPIC Study.帕金森病患者及左旋多巴 - 卡比多巴肠凝胶中GBA1变体的影响:一项全国性、多中心、纵向的“真实世界”研究。EPIC研究。
Eur J Neurol. 2025 Jul;32(7):e70179. doi: 10.1111/ene.70179.
3
Developing nanobodies as allosteric molecular chaperones of glucocerebrosidase function.

本文引用的文献

1
Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.对 12 个纵向患者队列中的帕金森病临床生物标志物进行全基因组关联研究。
Mov Disord. 2019 Dec;34(12):1839-1850. doi: 10.1002/mds.27845. Epub 2019 Sep 10.
2
Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.帕金森病的遗传风险与病情进展:对13个纵向队列的分析
Neurol Genet. 2019 Jul 9;5(4):e348. doi: 10.1212/NXG.0000000000000348. eCollection 2019 Aug.
3
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson's Disease and Dementia with Lewy Bodies.
开发纳米抗体作为葡萄糖脑苷脂酶功能的变构分子伴侣。
Nat Commun. 2025 May 27;16(1):4890. doi: 10.1038/s41467-025-60134-4.
4
AAV delivery of GBA1 suppresses α-synuclein accumulation in Parkinson's disease models and restores functions in Gaucher's disease models.通过腺相关病毒递送GBA1可抑制帕金森病模型中α-突触核蛋白的积累,并恢复戈谢病模型中的功能。
PLoS One. 2025 May 7;20(5):e0321145. doi: 10.1371/journal.pone.0321145. eCollection 2025.
5
Differences in age-related distribution of CSF alpha-synuclein seeding and Alzheimer profiles between PD with and without GBA1 variants.携带和不携带GBA1变体的帕金森病患者之间,脑脊液α-突触核蛋白种子和阿尔茨海默病特征的年龄相关分布差异。
NPJ Parkinsons Dis. 2025 May 5;11(1):107. doi: 10.1038/s41531-025-00978-1.
6
The potential of brain organoids in addressing the heterogeneity of synucleinopathies.脑类器官在解决突触核蛋白病异质性方面的潜力。
Cell Mol Life Sci. 2025 Apr 28;82(1):188. doi: 10.1007/s00018-025-05686-w.
7
Cholinergic Degeneration and Cognitive Function in Early GBA1-Related Parkinson's Disease.早期GBA1相关帕金森病中的胆碱能变性与认知功能
Ann Neurol. 2025 Apr 16. doi: 10.1002/ana.27248.
8
Significance of nicotine and nicotinic acetylcholine receptors in Parkinson's disease.尼古丁和烟碱型乙酰胆碱受体在帕金森病中的意义。
Front Aging Neurosci. 2025 Mar 21;17:1535310. doi: 10.3389/fnagi.2025.1535310. eCollection 2025.
9
Male sex accelerates cognitive decline in GBA1 Parkinson's disease.男性性别会加速GBA1型帕金森病的认知衰退。
NPJ Parkinsons Dis. 2025 Mar 4;11(1):41. doi: 10.1038/s41531-025-00883-7.
10
Acute Neuropsychiatric Decline in a Parkinson's Disease Patient with a Severe GBA1 Mutation Following Bilateral GPi Deep Brain Stimulation.一名携带严重GBA1突变的帕金森病患者在双侧苍白球内侧部脑深部电刺激后出现急性神经精神功能衰退
Mov Disord Clin Pract. 2025 Jun;12(6):875-877. doi: 10.1002/mdc3.70015. Epub 2025 Feb 24.
脑溶酶体活性在 GBA 相关帕金森病和路易体痴呆症及散发性中的特征。
Mol Neurobiol. 2019 Feb;56(2):1344-1355. doi: 10.1007/s12035-018-1090-0. Epub 2018 Jun 8.
4
Increased yield of full GBA sequencing in Ashkenazi Jews with Parkinson's disease.帕金森病阿什肯纳兹犹太人中全GBA测序产量增加。
Eur J Med Genet. 2019 Jan;62(1):65-69. doi: 10.1016/j.ejmg.2018.05.005. Epub 2018 May 26.
5
Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.葡萄糖脑苷脂酶多态性和突变与帕金森病发病后痴呆的关联。
Alzheimers Dement. 2018 Oct;14(10):1293-1301. doi: 10.1016/j.jalz.2018.04.006. Epub 2018 May 21.
6
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
7
The GBA variant E326K is associated with Parkinson's disease and explains a genome-wide association signal.GBA基因变体E326K与帕金森病相关,并解释了一个全基因组关联信号。
Neurosci Lett. 2017 Sep 29;658:48-52. doi: 10.1016/j.neulet.2017.08.040. Epub 2017 Aug 19.
8
Strategies for Enriching Variant Coverage in Candidate Disease Loci on a Multiethnic Genotyping Array.在多民族基因分型阵列上富集候选疾病位点变异覆盖度的策略
PLoS One. 2016 Dec 14;11(12):e0167758. doi: 10.1371/journal.pone.0167758. eCollection 2016.
9
Specifically neuropathic Gaucher's mutations accelerate cognitive decline in Parkinson's.具体而言,神经性戈谢病突变会加速帕金森病患者的认知衰退。
Ann Neurol. 2016 Nov;80(5):674-685. doi: 10.1002/ana.24781.
10
GBA p.T369M substitution in Parkinson disease: Polymorphism or association? A meta-analysis.GBA p.T369M 替换与帕金森病:多态性还是关联?一项荟萃分析。
Neurol Genet. 2016 Sep 8;2(5):e104. doi: 10.1212/NXG.0000000000000104. eCollection 2016 Oct.